Market research
INVO INVO Bioscience Inc
NASDAQ USD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 3M
- P/E ratio
- 1.21
- Analyst target
- 20
- Dividend yield
- Not available
- Beta
- 1.44
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US44984F3029
- Market cap
- 3M
- P/E ratio
- 1.21
- Analyst target
- 20
- Dividend yield
- Not available
- Beta
- 1.44
About
About INVO Bioscience Inc
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the INVO discussion.
5 years, 4 months ago
From a valuation standpoint, the stock is 97.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 39.0.
Based on the above factors, INVO Bioscience, Inc gets an overall score of 1/5.